A mutation discovered in people and livestock in China makes bacteria resistant to last-resort drugs.
A new report found bacteria resistant to colistin, a drug used when all other treatments have failed, in 16 patients, 15% of raw meat samples and a fifth of the animals tested. The mutation that made the bacteria resistant to the drug is called the MCR-1 gene, and spread resistance between various bacteria including E. coli.
Prof Timothy Walsh of the University of Cardiff, who worked on the study told BBC, “All the key players are now in place to make the post-antibiotic world a reality. If MCR-1 becomes global, which is a case of when not if, and the gene aligns itself with other antibiotic resistance genes, which is inevitable, then we will have very likely reached the start of the post-antibiotic era. At that point if a patient is seriously ill, say with E. coli, then there is virtually nothing you can do.”
More Must-Reads from TIME
- Introducing the 2024 TIME100 Next
- Sabrina Carpenter Has Waited Her Whole Life for This
- What Lies Ahead for the Middle East
- Why It's So Hard to Quit Vaping
- Jeremy Strong on Taking a Risk With a New Film About Trump
- Our Guide to Voting in the 2024 Election
- The 10 Races That Will Determine Control of the Senate
- Column: How My Shame Became My Strength
Write to Tessa Berenson Rogers at tessa.Rogers@time.com